Phase II Trial of Combined Modality Treatment in Primary Central Nervous System Lymphoma

Clinical trial NCT00210314 · COMPLETED

Trial details

NCT number: NCT00210314
Sponsor: International Extranodal Lymphoma Study Group (IELSG)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Lymphoma, B Cell

Start date: 2003-07-01
Primary completion: 2007-09-01
Enrollment: 79

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.